Sentences with phrase «in cell encapsulation»

Not exact matches

This crosslinking mechanism has been used to produce tissue sealants from polymers that are commonly used in tissue engineering studies — fibrinogen and gelatin (Elvin et al. 2011; Elvin et al. 2010), but so far, there have been relatively few studies using Ruthenium - mediated crosslinking for cell encapsulation.
In an effort to improve this, we employed an alginate encapsulation strategy for human mesenchymal stem cells (hMSCs) and attached them to the heart with a biocompatible PEG hydrogel patch in a rat MI modeIn an effort to improve this, we employed an alginate encapsulation strategy for human mesenchymal stem cells (hMSCs) and attached them to the heart with a biocompatible PEG hydrogel patch in a rat MI modein a rat MI model.
Exploitation of alternative cell sources (xenogeneic primary islets, stem cell derived beta cells) for utilization in our encapsulation device (collaboration with Anthony Gavalas, CRTD)
* Contains practical, hands - on information for tissue engineers and students * Provides comprehensive protocols covering numerous topics, including polymer synthesis, cell culture, encapsulation, bioreactors, therapeutics, and the creation of tissues and organs * Includes contributions by leaders in the latest areas of research, such as stem cells and fetal tissue engineering
The recent advances in xenotransplantation and particularly in the field of stem cell - derived beta cells have generated a renewed scientific interest in encapsulation technology.
In terms of which approaches people are taking which might bear fruit clinically most quickly; could you compare the transplantation encapsulation strategies with a stem cell based immune response - centered approach?
The VC - 01 combination product is based on the production of pancreatic progenitor cells (PEC - 01 ™ cells), which are implanted in a durable and retrievable encapsulation device, known as the Encaptra ® drug delivery system.
Its core expertise is in efficient differentiation and encapsulation of human stem cells for therapeutic applications in diabetes.
Our therapy is based on the encapsulation and implantation of pancreatic beta cell progenitors (Pro-Islet-1) derived from human stem cells which secrete insulin in patients.
We then evaluated whether the encapsulation of hPSC - CDH5 + cells in PA - RGDS could enhance long - term cell survival and vascular regenerative effects in a hind - limb ischemia model with laser Doppler perfusion imaging, bioluminescence imaging, real - time reverse transcription - polymerase chain reaction, and histological analysis.
ViaCyte's product candidates are based on the derivation of pancreatic progenitor cells, which are then implanted in a durable and retrievable encapsulation device.
These cells are implanted in a durable and retrievable encapsulation device called the Encaptra ® drug delivery system.
Thanks to a breakthrough in solar cell structure and encapsulation techniques by the Frauenhofer Institute, solar cells integrated into complex surfaces are expected to be on the shelves by the end of this year.
a b c d e f g h i j k l m n o p q r s t u v w x y z